The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome
Open accessAbstract
Clinical syndromes associated with progressive supranuclear palsy-tau pathology now include progressive supranuclear palsy-parkinsonism (PSP-P), in addition to classic Richardson's syndrome (RS) and pure akinesia with gait freezing (PAGF). Although pathological heterogeneity of progressive supranuclear palsy (PSP) has also been established, attempts to correlate this with clinical findings have only rarely provided conclusive results. The aim of this study was to investigate whether regional variations in the types of tau lesions or differences in overall tau load may explain the clinical differences between the RS, PSP-P and PAGF. Quantitative tau pathology assessment was performed in 17 brain regions in 42 cases of pathologically diagnosed PSP (22 RS, 14 PSP-P and 6 PAGF). Neurofibrillary tangles, tufted astrocytes, coiled bodies and thread pathology were quantitated and a grading system was developed separately for each region. Using these grades the overall tau load was calculated in each case. To establish a simplified system for grading the severity of tau pathology, all data were explored to identify the minimum number of regions that satisfactorily summarized the overall tau severity. The subthalamic nucleus, substantia nigra and globus pallidus were consistently the regions most severely affected by tau pathology. The mean severity in all regions of the RS group was higher than in PSP-P and PAGF, and the overall tau load was significantly higher in RS than in PSP-P (P = 0.002). Using only the grade of coiled body + thread lesions in the substantia nigra, caudate and dentate nucleus, a reliable and repeatable 12-tiered grading system was established (PSP-tau score: 0, mild tau pathology, restricted distribution; >7, severe, widespread tau pathology). PSP-tau score was negatively correlated with disease duration (Spearman's rho −0.36, P = 0.028) and time from disease onset to first fall (Spearman's rho −0.49, P = 0.003). The PSP-tau score in PSP-P (median 3, range 0–5) was significantly lower than in RS (median 5, range 2–10, Mann–Whitney U, P < 0.001). The two cases carrying the tau-H2 protective allele had the two lowest PSP-tau scores. We have identified significant pathological differences between the major clinical syndromes associated with PSP-tau pathology and the restricted, mild tau pathology in PSP-P supports its clinical distinction from RS. The grading system we have developed provides an easy-to-use and sensitive tool for the morphological assessment of PSP-tau pathology and allows for consideration of the clinical diversity that is known to occur in PSP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
STEELE, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,924
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech
Josephs, K. A. (2006) · Brain · doi:10.1093/brain/awl078 · Cited by 689
Williams, D. R., de Silva, R., Paviour, D. C., Pittman, A., Watt, H. C., Kilford, L., Holton, J. L., Revesz, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 667
Self-citationLitvan, I., Hauw, J. J., Bartko, J. J., Lantos, P. L., Daniel, S. E., Horoupian, D. S., McKee, A., Dickson, D., Bancher, C., Tabaton, M., et al. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199601000-00010 · Cited by 475
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
Dickson, D. W. (1999) · Journal of Neurology · doi:10.1007/bf03161076 · Cited by 416
Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View
Revesz, T., Ghiso, J., Lashley, T., Plant, G., Rostagno, A., Frangione, B., & Holton, J. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.885 · Cited by 288
Self-citationDaniel, S. E., de Bruin, V. M. S., & Lees, A. J. (1995) · Brain · doi:10.1093/brain/118.3.759 · Cited by 274
Self-citationArgyrophilic Grain Disease Is a Sporadic 4-Repeat Tauopathy
Togo, T., Sahara, N., Yen, S.-H., Cookson, N., Ishizawa, T., Hutton, M., de Silva, R., Lees, A., & Dickson, D. W. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.6.547 · Cited by 273
Self-citationPittman, A. M., Myers, A. J., Abou-Sleiman, P., Fung, H. C., Kaleem, M., Marlowe, L., Duckworth, J., Leung, D., Williams, D., Kilford, L., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031377 · Cited by 272
Self-citationWilliams, D. R. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01153.x · Cited by 259
Self-citationMyers, A. J., Pittman, A. M., Zhao, A. S., Rohrer, K., Kaleem, M., Marlowe, L., Lees, A., Leung, D., McKeith, I. G., Perry, R. H., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.018 · Cited by 255
Self-citationDe Silva, R., Lashley, T., Gibb, G., Hanger, D., Hope, A., Reid, A., Bandopadhyay, R., Utton, M., Strand, C., Jowett, T., et al. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00463.x · Cited by 220
Self-citationPaviour, D. C., Price, S. L., Jahanshahi, M., Lees, A. J., & Fox, N. C. (2006) · Brain · doi:10.1093/brain/awl021 · Cited by 218
Self-citationJosephs, K. A., Boeve, B. F., Duffy, J. R., Smith, G. E., Knopman, D. S., Parisi, J. E., Petersen, R. C., & Dickson, D. W. (2005) · Neurocase · doi:10.1080/13554790590963004 · Cited by 192
Komori, T., Arai, N., Oda, M., Nakayama, H., Mori, H., Yagishita, S., Takahashi, T., Amano, N., Murayama, S., Murakami, S., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050911 · Cited by 165
Tau gene mutations and their effects
Goedert, M. (2005) · Movement Disorders · doi:10.1002/mds.20539 · Cited by 160
Tsuboi, Y., Josephs, K. A., Boeve, B. F., Litvan, I., Caselli, R. J., Caviness, J. N., Uitti, R. J., Bott, A. D., & Dickson, D. W. (2005) · Movement Disorders · doi:10.1002/mds.20478 · Cited by 145
Verny, M., Duyckaerts, C. J., Agid, Y., & Hauw, J. (1996) · Brain · doi:10.1093/brain/119.4.1123 · Cited by 134
Hof, P. R., Delacourte, A., & Bouras, C. (1992) · Acta Neuropathologica · doi:10.1007/bf00427214 · Cited by 130
Richardson, J. C., Steele, J. C., & Olszewski, J. (1963) · PubMed · Cited by 125
Buée‐Scherrer, V., Buée, L., Hof, P. R., Leveugle, B., Mourton-Gilles, C., Loerzel, A. J., Perl, D. P., & Delacourte, A. (1995) · Europe PMC (PubMed Central) · Cited by 122
Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles
Probst, A., Langui, D., Lautenschläger, C., ULRICH, J., Brion, J., & Anderton, B. H. (1988) · Acta Neuropathologica · doi:10.1007/bf00688244 · Cited by 115
Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles
Geddes, J. F., Hughes, A. J., Lees, A. J., & Daniel, S. E. (1993) · Brain · doi:10.1093/brain/116.1.281 · Cited by 115
Self-citationBergeron, C., Pollanen, Weyer, L., & Lang, A. E. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199706000-00010 · Cited by 110
Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy
Ikeda, K., Akiyama, H., Haga, C., Kondo, H., Arima, K., & Oda, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90010-8 · Cited by 94
Mesencephalic cholinergic nuclei in progressive supranuclear palsy
Juncos, J. L., Hirsch, É. C., Malessa, S., Duyckaerts, C. J., Hersh, L. B., & Agid, Y. (1991) · Neurology · doi:10.1212/wnl.41.1.25 · Cited by 90
Progressive Supranuclear Palsy with Dementia: Cortical Pathology
Bigio, E. H., Brown, D. F., & White, C. L. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199904000-00006 · Cited by 88
Buée‐Scherrer, V., Buée, L., Leveugle, B., Perl, D. P., Vermersch, P., Hof, P. R., & Delacourte, A. (1997) · Annals of Neurology · doi:10.1002/ana.410420312 · Cited by 71
Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia
Sundar, P. D., Yu, C., Sieh, W., Steinbart, E. J., Garruto, R. M., Oyanagi, K., Craig, U.-K., Bird, T. D., Wijsman, E. M., Galasko, D. R., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl463 · Cited by 69
Allocortical neurofibrillary changes in progressive supranuclear palsy
Braak, H., Jellinger, K. A., Braak, E., & Böhl, J. (1992) · Acta Neuropathologica · doi:10.1007/bf00304466 · Cited by 63
Mawal-Dewan, M., Schmidt, L. M., Balin, B. J., Perl, D. P., Lee, V. M. ‐., & Trojanowski, J. Q. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199655100-00005 · Cited by 60
Révész, T., Sangha, H., & Daniel, S. E. (1996) · Brain · doi:10.1093/brain/119.4.1137 · Cited by 53
Oyanagi, K., Makifuchi, T., Ohtoh, T., Chen, K.-M., Gajdusek, D. C., & Chase, T. N. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199703000-00010 · Cited by 52
Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration
Piao, Y.-S., Hayashi, S., Wakabayashi, K., Kakita, A., Aida, I., Yamada, M., & Takahashi, H. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0488-2 · Cited by 51
A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy
Halliday, G. M. (2000) · Brain · doi:10.1093/brain/123.4.724 · Cited by 49
Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls
Tsuboi, Y., Ahlskog, J. E., Apaydın, H., Parisi, J. E., & Dickson, D. W. (2001) · Neurology · doi:10.1212/wnl.57.9.1675 · Cited by 48
Oyanagi, K., Tsuchiya, K., Yamazaki, M., & Ikeda, K. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.393 · Cited by 46
Oyanagi, K. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.02.010 · Cited by 39
Progressive supranuclear palsy presenting with pure akinesia.
Mizusawa, H., Mochizuki, A., Ohkoshi, N., Yoshizawa, K., Kanazawa, I., & Imai, H. (1993) · PubMed · Cited by 39
Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
Imai, H., Nakamura, T., Kondo, T., & Narabayashi, H. (1993) · PubMed · Cited by 34
Parkinsonism, dementia and vertical gaze palsy in a Guamanian with atypical neuroglial degeneration
Oyanagi, K., Chen, K. M., Craig, U.-K., Yamazaki, M., & Perl, D. P. (2000) · Acta Neuropathologica · doi:10.1007/pl00007410 · Cited by 11
Cited by
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Initiative, A. D. N., Shi, Y., Yamada, K., Liddelow, S. A., Smith, S. T., Zhao, L., Luo, W., Tsai, R. M., Spina, S., Grinberg, L. T., et al. (2017) · Nature · doi:10.1038/nature24016 · Cited by 1,220
Neuroinflammation as a common feature of neurodegenerative disorders
Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01008 · Cited by 702
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges
Williams, D. R., & Lees, A. J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70042-0 · Cited by 650
Self-citationTau PET imaging in neurodegenerative tauopathies—still a challenge
Leuzy, A., Chiotis, K., Lemoine, L., Gillberg, P.-G., Almkvist, O., Rodriguez-Vieitez, E., & Nordberg, A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0342-8 · Cited by 628
Neuropathology of Parkinson disease
Dickson, D. W. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.033 · Cited by 623
Metadata
- Authors
- Williams, D. R., Holton, J. L., Strand, C., Pittman, A., de Silva, R., Lees, A. J., & Revesz, T.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-01
- Volume
- 130
- Issue
- 6
- Pages
- 1566-1576
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2018765794
- Cited by
- 417
- References
- 48
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.